Motixafortide and pembrolizumab combined to nanoliposomal irinotecan, fluorouracil, and folinic acid in metastatic pancreatic cancer: The COMBAT/ KEYNOTE-202 trial

1. Bockorny, B.
2. Macarulla, T.
3. Semenisty, V.
4. Borazanci, E.
5. Feliu, J.
6. Ponz-Sarvise, M.
7. Abad, D.G.
8. Oberstein, P.
9. Alistar, A.
10. Muñoz, A.
11. Geva, R.
12. Guillen-Ponce, C.
13. Fernandez, M.S.
14. Peled, A.
15. Chaney, M.
16. Gliko-Kabir, I.
17. Shemesh-Darvish, L.
18. Ickowicz, D.
19. Sorani, E.
20. Kadosh, S.
21. Vainstein-Haras, A.
22. Hidalgo, M.